Clinical Trials for Haydar Frangoul

17 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
Basic ScienceCOGAAML08B1
10/26/2011
AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Basic ScienceCOGAALL08B1
10/18/2010
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Basic ScienceCOGAALL05B1
12/01/2006
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Basic ScienceNMDPBMT0346
07/09/2003
Repository for National Donor Program (NMDP) Research Blood Samples.
OtherVICCPED0995
02/18/2010
Detection of Donor-Derived DNA in Semen Samples Among Recipients of Allogeneic Hematopoietic Stem-Cell Transplants
Supportive CareVICCNCPED1210
02/20/2012
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients with Dystrophic Epidermolysis Bullosa.
Supportive CareCOGACCL0933
11/16/2011
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
TreatmentVICCPED1365
04/16/2014
T2011-002: A Phase I Study of 5-Azacytidine in Combination with Chemotherapy for Children with Relapsed or Refractory ALL or AML
TreatmentVICCPED1355
03/05/2014
Multi-Center, Open-Label Ranodomized Study of Single or Double Myleoablative Cord Blood Transplantation With or Without Infusion of Off-the-Shelf Ex Vivo Expanded Cyropreserved Cord Blood Progenitor Cells in Patients with Hematologic Malignancies
TreatmentVICCPED1338
06/27/2013
T2009-012 - A Phase I Dose Finding Study of Panobinostat in Children with Refractory Hematologic Malignancies
TreatmentCOGANBL12P1
06/05/2013
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma
TreatmentVICCPED1249
08/06/2012
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
TreatmentCOGAALL1131
04/05/2012
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC# 606869) in the Very High Risk Stratum
TreatmentVICCBMT1158
10/20/2011
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and other Indications
TreatmentCOGAALL0932
11/11/2010
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
TreatmentCOGAALL0631
09/09/2008
A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy =/+ FLT3 Inhibition
TreatmentVICCNCPED10101
12/28/2006
Hematopoietic Cell Transplantation for Treatment of Patients with Primary Immunodeficiencies and Other Nonmalignant Inherited Disorders Using Low-Dose TBI and Fludarabine with or without Campath

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.